Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3525LS1M
Performance in the last:
Follow this Portfolio
1D -0.6 %
1W 1.9 %
2W 0.2 %
1M -0.5 %
3M 1.1 %
6M -39.7 %
9M -33.5 %
1Y -32.3 %
Alpha
-47.9%
Beta
0.63
sharpe-R
-0.65
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.16
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-09-18 07:49:55
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -47.92%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 1 Month in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 25.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
AGEN Agenus Inc. Equity Buy 6.7% 13.89%
AADI Aadi Bioscience, Inc. Equity Buy 6.55% 5.14%
PODD Insulet Corporation Equity Buy 10.24% 15.22%
ESPR Esperion Therapeutics, Inc. Equity Buy 8.54% -2.73%
NVCR NovoCure Limited Equity Buy 7.76% -0.17%
MYGN Myriad Genetics, Inc. Equity Buy 7.83% 6.04%
STAA STAAR Surgical Company Equity Sell -3.93% 0.59%
LMAT LeMaitre Vascular, Inc. Equity Sell -3.87% 0.25%
AVXL Anavex Life Sciences Corp. Equity Sell -3.6% 7.14%
CERS Cerus Corporation Equity Sell -3.88% 6.64%
The percentage of cash held in the portfolio is: 67.67%
** The description of each asset is available Here

The latest 5 Compositions change

2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 6.59% 11.15%
AADI Aadi Bioscience, Inc. Buy 6.74% 7.43%
PODD Insulet Corporation Buy 10.24% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 8.5% -3.83%
NVCR NovoCure Limited Buy 7.78% -0.5%
MYGN Myriad Genetics, Inc. Buy 7.69% 3.45%
STAA STAAR Surgical Company Sell -3.86% 3.06%
LMAT LeMaitre Vascular, Inc. Sell -3.95% -1.08%
AVXL Anavex Life Sciences Corp. Sell -3.79% 3.06%
CERS Cerus Corporation Sell -4.09% 2.37%
The percentage of cash held in the portfolio is: 68.14%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -2.28%
APLS Sell All -8.89%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.8% -3.75%
AGEN Agenus Inc. Buy 6.22% 3.11%
AADI Aadi Bioscience, Inc. Buy 6.72% 5.14%
PODD Insulet Corporation Buy 10.15% 11.4%
MGNX MacroGenics, Inc. Buy 9.28% 3.13%
ESPR Esperion Therapeutics, Inc. Buy 8.55% -4.92%
TVTX Travere Therapeutics, Inc. Buy 8.84% 27.5%
NVCR NovoCure Limited Buy 7.6% -4.54%
MYGN Myriad Genetics, Inc. Buy 7.37% -2.56%
STAA STAAR Surgical Company Sell -3.79% 6.36%
LMAT LeMaitre Vascular, Inc. Sell -3.87% 2.57%
AVXL Anavex Life Sciences Corp. Sell -3.47% 12.76%
CERS Cerus Corporation Sell -4.14% 2.84%
The percentage of cash held in the portfolio is: 44.75%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 2.22%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.92% -1.69%
AGEN Agenus Inc. Buy 6.01% -0.18%
AADI Aadi Bioscience, Inc. Buy 6.49% 1.71%
PODD Insulet Corporation Buy 10.08% 10.8%
MGNX MacroGenics, Inc. Buy 9.11% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 8.49% -5.46%
TVTX Travere Therapeutics, Inc. Buy 9.27% 33.75%
NVCR NovoCure Limited Buy 7.45% -6.37%
MYGN Myriad Genetics, Inc. Buy 7.57% 0.26%
STAA STAAR Surgical Company Sell -3.77% 6.89%
LMAT LeMaitre Vascular, Inc. Sell -3.85% 3.03%
AVXL Anavex Life Sciences Corp. Sell -3.38% 14.88%
VREX Varex Imaging Corporation Sell -4.13% 2.99%
CERS Cerus Corporation Sell -4.14% 2.84%
The percentage of cash held in the portfolio is: 48.87%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Buy All 0.85%
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6.01% 0.21%
CARA Cara Therapeutics, Inc. Buy 5.42% -9.62%
AGEN Agenus Inc. Buy 5.62% -6.22%
AADI Aadi Bioscience, Inc. Buy 6.57% 3.43%
PODD Insulet Corporation Buy 9.71% 7.2%
MGNX MacroGenics, Inc. Buy 8.79% -1.71%
ESPR Esperion Therapeutics, Inc. Buy 8.31% -7.1%
TVTX Travere Therapeutics, Inc. Buy 9.24% 33.96%
NVCR NovoCure Limited Buy 7.28% -7.98%
MYGN Myriad Genetics, Inc. Buy 7.57% 0.63%
CDMO Avid Bioservices, Inc. Sell -3.36% 15.41%
STAA STAAR Surgical Company Sell -3.74% 7.17%
LMAT LeMaitre Vascular, Inc. Sell -3.84% 2.83%
AVXL Anavex Life Sciences Corp. Sell -3.46% 12.41%
VREX Varex Imaging Corporation Sell -3.71% 12.56%
CERS Cerus Corporation Sell -4.06% 4.27%
The percentage of cash held in the portfolio is: 47.66%
New Assets Added
None
Assets Removed
Asset Action Perf %
BGNE Buy All -0.8%
PACB Buy All -22.96%
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6.3% 3%
CARA Cara Therapeutics, Inc. Buy 5.75% -6.12%
AGEN Agenus Inc. Buy 5.54% -9.51%
AADI Aadi Bioscience, Inc. Buy 6.78% 4.57%
PODD Insulet Corporation Buy 9.71% 5.05%
MGNX MacroGenics, Inc. Buy 8.46% -7.41%
ESPR Esperion Therapeutics, Inc. Buy 8.23% -9.84%
TVTX Travere Therapeutics, Inc. Buy 8.05% 14.37%
ALDX Aldeyra Therapeutics, Inc. Buy 7.86% -3.01%
NVCR NovoCure Limited Buy 7.56% -6.48%
MYGN Myriad Genetics, Inc. Buy 7.68% 0%
CDMO Avid Bioservices, Inc. Sell -3.39% 16.54%
STAA STAAR Surgical Company Sell -3.95% 3.86%
LMAT LeMaitre Vascular, Inc. Sell -3.99% 1.1%
AVXL Anavex Life Sciences Corp. Sell -3.54% 12.41%
PACB Pacific Biosciences of California, Inc. Sell -4.73% -17.04%
BGNE BeiGene, Ltd. Sell -2.25% 0.24%
VREX Varex Imaging Corporation Sell -4.27% 1.28%
CERS Cerus Corporation Sell -4.14% 4.27%
The percentage of cash held in the portfolio is: 48.34%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.99% -1.42%
ORGO Organogenesis Holdings Inc. Buy 5.67% -6.71%
CARA Cara Therapeutics, Inc. Buy 5.69% -6.41%
AGEN Agenus Inc. Buy 5.56% -8.59%
AADI Aadi Bioscience, Inc. Buy 6.63% 2.86%
PODD Insulet Corporation Buy 9.71% 5.72%
MGNX MacroGenics, Inc. Buy 8.74% -3.7%
ESPR Esperion Therapeutics, Inc. Buy 8.53% -6.01%
TVTX Travere Therapeutics, Inc. Buy 7.23% 3.44%
ALDX Aldeyra Therapeutics, Inc. Buy 8.05% 0%
NVCR NovoCure Limited Buy 8.03% 0%
CDMO Avid Bioservices, Inc. Sell -3.43% 14.93%
STAA STAAR Surgical Company Sell -3.94% 3.61%
LMAT LeMaitre Vascular, Inc. Sell -3.97% 1.07%
AVXL Anavex Life Sciences Corp. Sell -3.79% 5.44%
PACB Pacific Biosciences of California, Inc. Sell -4.16% -3.7%
BGNE BeiGene, Ltd. Sell -2.24% 0.1%
VREX Varex Imaging Corporation Sell -4.4% -2.31%
CERS Cerus Corporation Sell -4.24% 1.42%
The percentage of cash held in the portfolio is: 50.33%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.76% -5.21%
ORGO Organogenesis Holdings Inc. Buy 5.79% -4.59%
CARA Cara Therapeutics, Inc. Buy 5.7% -6.12%
AGEN Agenus Inc. Buy 5.38% -11.33%
AADI Aadi Bioscience, Inc. Buy 6.62% 2.86%
PODD Insulet Corporation Buy 9.54% 3.96%
MGNX MacroGenics, Inc. Buy 8.57% -5.41%
ESPR Esperion Therapeutics, Inc. Buy 9.01% -0.55%
TVTX Travere Therapeutics, Inc. Buy 7.31% 4.69%
ALDX Aldeyra Therapeutics, Inc. Buy 8.04% 0%
CDMO Avid Bioservices, Inc. Sell -3.52% 12.67%
STAA STAAR Surgical Company Sell -3.97% 2.72%
LMAT LeMaitre Vascular, Inc. Sell -3.98% 0.61%
AVXL Anavex Life Sciences Corp. Sell -3.83% 4.42%
PACB Pacific Biosciences of California, Inc. Sell -3.92% 2.22%
BGNE BeiGene, Ltd. Sell -2.2% 1.63%
VREX Varex Imaging Corporation Sell -4.29% 0%
CERS Cerus Corporation Sell -4.29% 0%
The percentage of cash held in the portfolio is: 58.28%
New Assets Added
  • VREX
  • CERS
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.93% -2.65%
ORGO Organogenesis Holdings Inc. Buy 5.87% -3.53%
CARA Cara Therapeutics, Inc. Buy 5.88% -3.5%
AGEN Agenus Inc. Buy 5.51% -9.51%
CERS Cerus Corporation Buy 5.94% -7.98%
AADI Aadi Bioscience, Inc. Buy 6.41% -0.57%
PODD Insulet Corporation Buy 9.3% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.24% -10.38%
MGNX MacroGenics, Inc. Buy 8.49% -6.55%
ESPR Esperion Therapeutics, Inc. Buy 9.08% 0%
TVTX Travere Therapeutics, Inc. Buy 7% 0%
CDMO Avid Bioservices, Inc. Sell -3.71% 8.03%
STAA STAAR Surgical Company Sell -4.08% 0.15%
LMAT LeMaitre Vascular, Inc. Sell -3.95% 1.75%
AVXL Anavex Life Sciences Corp. Sell -3.73% 7.14%
PACB Pacific Biosciences of California, Inc. Sell -3.99% 0.74%
BGNE BeiGene, Ltd. Sell -2.2% 1.84%
The percentage of cash held in the portfolio is: 44.01%
New Assets Added
  • TVTX
Assets Removed
Asset Action Perf %
PINC Buy All -4.4%
VERU Buy All -12.35%
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-09-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.72% -2.98%
APLS Apellis Pharmaceuticals, Inc. Buy 5.75% -2.4%
ORGO Organogenesis Holdings Inc. Buy 6% 1.77%
CARA Cara Therapeutics, Inc. Buy 6.19% 4.96%
AGEN Agenus Inc. Buy 5.55% -5.85%
CERS Cerus Corporation Buy 5.93% -5.04%
AADI Aadi Bioscience, Inc. Buy 6.46% 3.43%
NEOG Neogen Corporation Buy 7.2% 0.35%
PODD Insulet Corporation Buy 8.83% -0.81%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.8% -1.15%
MGNX MacroGenics, Inc. Buy 8.79% 0%
ESPR Esperion Therapeutics, Inc. Buy 8.79% 0%
CDMO Avid Bioservices, Inc. Sell -3.89% 0.38%
STAA STAAR Surgical Company Sell -4.05% -2.22%
PINC Premier, Inc. Sell -4.08% -2.93%
LMAT LeMaitre Vascular, Inc. Sell -3.94% -1.4%
AVXL Anavex Life Sciences Corp. Sell -3.98% -2.38%
VERU Veru Inc. Sell -3.94% -1.23%
PACB Pacific Biosciences of California, Inc. Sell -3.95% -1.48%
BGNE BeiGene, Ltd. Sell -2.17% 0%
The percentage of cash held in the portfolio is: 45.97%
New Assets Added
  • BGNE
  • MGNX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-08-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.67% -3.77%
APLS Apellis Pharmaceuticals, Inc. Buy 5.72% -2.85%
ORGO Organogenesis Holdings Inc. Buy 6.03% 2.47%
CARA Cara Therapeutics, Inc. Buy 6.04% 2.62%
AGEN Agenus Inc. Buy 5.37% -8.78%
CERS Cerus Corporation Buy 6% -3.78%
AADI Aadi Bioscience, Inc. Buy 6.24% 0%
NEOG Neogen Corporation Buy 7.14% -0.41%
PODD Insulet Corporation Buy 8.93% 0.36%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.97% 0.77%
CDMO Avid Bioservices, Inc. Sell -3.82% 2.08%
STAA STAAR Surgical Company Sell -3.93% 0.71%
PINC Premier, Inc. Sell -4.04% -2.07%
LMAT LeMaitre Vascular, Inc. Sell -3.87% 0.47%
AVXL Anavex Life Sciences Corp. Sell -3.94% -1.53%
VERU Veru Inc. Sell -3.93% -1.23%
PACB Pacific Biosciences of California, Inc. Sell -3.91% -0.74%
The percentage of cash held in the portfolio is: 61.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
LXRX Buy All 19.28%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.69% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 5.64% -4.2%
ORGO Organogenesis Holdings Inc. Buy 6.1% 3.53%
CARA Cara Therapeutics, Inc. Buy 6.11% 3.79%
AGEN Agenus Inc. Buy 5.5% -6.58%
CERS Cerus Corporation Buy 5.87% -5.88%
AADI Aadi Bioscience, Inc. Buy 5.99% -4%
NEOG Neogen Corporation Buy 7.01% -2.15%
PODD Insulet Corporation Buy 8.9% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.9% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.82% 22.87%
CDMO Avid Bioservices, Inc. Sell -3.77% 3.4%
STAA STAAR Surgical Company Sell -3.9% 1.42%
PINC Premier, Inc. Sell -3.97% -0.3%
LMAT LeMaitre Vascular, Inc. Sell -3.88% 0%
AVXL Anavex Life Sciences Corp. Sell -3.88% 0%
VERU Veru Inc. Sell -3.88% 0%
PACB Pacific Biosciences of California, Inc. Sell -3.88% 0%
The percentage of cash held in the portfolio is: 64.28%
New Assets Added
  • LMAT
  • AVXL
  • VERU
  • PACB
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.68% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 5.78% -0.64%
ORGO Organogenesis Holdings Inc. Buy 6.05% 3.89%
CARA Cara Therapeutics, Inc. Buy 6.09% 4.66%
AGEN Agenus Inc. Buy 5.99% 2.93%
CERS Cerus Corporation Buy 6.01% -2.52%
AADI Aadi Bioscience, Inc. Buy 5.92% -4%
NEOG Neogen Corporation Buy 7.08% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.78% 22.87%
CDMO Avid Bioservices, Inc. Sell -3.75% 2.74%
STAA STAAR Surgical Company Sell -3.91% 0%
PINC Premier, Inc. Sell -3.91% 0%
The percentage of cash held in the portfolio is: 65.75%
New Assets Added
  • STAA
  • PINC
  • NEOG
Assets Removed
Asset Action Perf %
CYH Sell All 4.72%
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.5% 6.09%
ARDX Ardelyx, Inc. Buy 5.7% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 5.75% -0.05%
ORGO Organogenesis Holdings Inc. Buy 6.16% 7.07%
CARA Cara Therapeutics, Inc. Buy 6.21% 7.87%
AGEN Agenus Inc. Buy 6.18% 7.31%
CERS Cerus Corporation Buy 6.1% 0%
AADI Aadi Bioscience, Inc. Buy 6.1% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.83% 20.63%
CDMO Avid Bioservices, Inc. Sell -3.74% 2.08%
The percentage of cash held in the portfolio is: 56.87%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.12% -0.59%
ARDX Ardelyx, Inc. Buy 5.81% -0.31%
APLS Apellis Pharmaceuticals, Inc. Buy 5.86% 0.64%
ORGO Organogenesis Holdings Inc. Buy 6.03% 3.53%
CARA Cara Therapeutics, Inc. Buy 5.91% 1.46%
AGEN Agenus Inc. Buy 6.18% 6.03%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.97% 17.94%
CDMO Avid Bioservices, Inc. Sell -3.86% 0%
The percentage of cash held in the portfolio is: 69.92%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 6.96% -4.32%
ARDX Ardelyx, Inc. Buy 5.62% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 5.81% -1.79%
ORGO Organogenesis Holdings Inc. Buy 5.75% -2.83%
CARA Cara Therapeutics, Inc. Buy 5.91% 0%
AGEN Agenus Inc. Buy 5.91% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.01% 17.94%
The percentage of cash held in the portfolio is: 67.06%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.02% -2.95%
ARDX Ardelyx, Inc. Buy 5.88% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 5.88% 0%
ORGO Organogenesis Holdings Inc. Buy 5.88% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.12% 14.35%
The percentage of cash held in the portfolio is: 78.46%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.08% -1.57%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.7% 25.56%
The percentage of cash held in the portfolio is: 95.62%
New Assets Added
None
Assets Removed
Asset Action Perf %
EGRX Buy All 4.43%
NKTR Buy All 7.41%
RCM Sell All 7.37%
Assets Rebalanced
None
2024-08-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 6.55% 7.37%
CYH Community Health Systems, Inc. Buy 6.8% -4.91%
NKTR Nektar Therapeutics Sell -3.02% 17.78%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.59% 28.25%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.11% 13.71%
The percentage of cash held in the portfolio is: 95.38%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All 13.64%
AVNS Sell All 6.33%
SGRY Sell All 16.4%
RGNX Sell All -8.1%
ANGO Sell All 21.37%
Assets Rebalanced
None
2024-08-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.7% 8.33%
AVNS Avanos Medical, Inc. Buy 6.52% 8.69%
SGRY Surgery Partners, Inc. Buy 7.04% 17.34%
RGNX REGENXBIO Inc. Buy 5.05% -6.45%
ANGO AngioDynamics, Inc. Buy 7.56% 23.82%
RCM R1 RCM Inc. Buy 6.55% 7.21%
CYH Community Health Systems, Inc. Buy 6.95% -2.95%
NKTR Nektar Therapeutics Sell -3.3% 10.37%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.72% 24.66%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.16% 12.45%
The percentage of cash held in the portfolio is: 63.81%
New Assets Added
None
Assets Removed
Asset Action Perf %
CPRX Buy All -6.15%
PODD Buy All -2.48%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.15% -3.03%
AVNS Avanos Medical, Inc. Buy 6.42% 6.19%
SGRY Surgery Partners, Inc. Buy 6.77% 11.98%
RGNX REGENXBIO Inc. Buy 5.16% -5.27%
ANGO AngioDynamics, Inc. Buy 7.26% 17.78%
RCM R1 RCM Inc. Buy 6.6% 7.14%
CYH Community Health Systems, Inc. Buy 6.67% -7.66%
PODD Insulet Corporation Sell -3.63% 2.34%
NKTR Nektar Therapeutics Sell -3.25% 12.59%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.55% 30.04%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.27% 10.34%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.83% 5.86%
The percentage of cash held in the portfolio is: 72.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
INGN Buy All -20.7%
RMD Sell All 1.39%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.14% -0.76%
AVNS Avanos Medical, Inc. Buy 6.39% 8.36%
SGRY Surgery Partners, Inc. Buy 6.63% 12.41%
RGNX REGENXBIO Inc. Buy 5.23% -1.57%
ANGO AngioDynamics, Inc. Buy 7.33% 22.02%
RCM R1 RCM Inc. Buy 6.43% 7.06%
CYH Community Health Systems, Inc. Buy 6.67% -5.3%
RMD ResMed Inc. Buy 13.94% 3.67%
PODD Insulet Corporation Sell -3.54% 2.25%
NKTR Nektar Therapeutics Sell -3.14% 13.33%
INGN Inogen, Inc. Sell -3.17% 10.89%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.42% 31.84%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.27% 8.02%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.56% 10.15%
The percentage of cash held in the portfolio is: 61.35%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All -10.51%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.25% 2.27%
PDSB PDS Biotechnology Corporation Buy 4.12% -8.52%
AVNS Avanos Medical, Inc. Buy 6.63% 13.36%
SGRY Surgery Partners, Inc. Buy 6.65% 13.78%
RGNX REGENXBIO Inc. Buy 5.4% 2.6%
ANGO AngioDynamics, Inc. Buy 7.55% 26.75%
RCM R1 RCM Inc. Buy 6.42% 7.83%
CYH Community Health Systems, Inc. Buy 6.85% -1.96%
RMD ResMed Inc. Buy 14.32% 7.5%
PODD Insulet Corporation Sell -3.62% -0.76%
NKTR Nektar Therapeutics Sell -3.19% 11.11%
INGN Inogen, Inc. Sell -3.28% 6.97%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.69% 23.77%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.42% 2.95%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.75% 4.47%
The percentage of cash held in the portfolio is: 56.77%
New Assets Added
None
Assets Removed
Asset Action Perf %
RARE Buy All -17.98%
CUTR Sell All -19.59%
HQY Sell All -11.82%
SAVA Sell All 95.11%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.49% 4.55%
PDSB PDS Biotechnology Corporation Buy 4.23% -8.24%
AVNS Avanos Medical, Inc. Buy 6.71% 12.13%
SGRY Surgery Partners, Inc. Buy 7.08% 18.28%
RGNX REGENXBIO Inc. Buy 5.64% 4.72%
ANGO AngioDynamics, Inc. Buy 7.75% 27.08%
CUTR Cutera, Inc. Buy 4.59% -12.16%
RCM R1 RCM Inc. Buy 6.61% 8.44%
CYH Community Health Systems, Inc. Buy 7.04% -1.57%
HQY HealthEquity, Inc. Buy 6.87% -3.84%
SAVA Cassava Sciences, Inc. Buy 11.26% 57.44%
HCSG Healthcare Services Group, Inc. Buy 2.46% -3.72%
RMD ResMed Inc. Buy 14.06% 3.13%
PODD Insulet Corporation Sell -3.72% -1.17%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.79% -3.2%
NKTR Nektar Therapeutics Sell -3.46% 5.93%
INGN Inogen, Inc. Sell -3.58% 0.87%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.27% 9.42%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.64% -0.84%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.95% 1.8%
The percentage of cash held in the portfolio is: 35.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Sell All -12.39%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.62% 7.58%
PDSB PDS Biotechnology Corporation Buy 4.64% 1.14%
AVNS Avanos Medical, Inc. Buy 6.72% 12.94%
SGRY Surgery Partners, Inc. Buy 7.07% 18.83%
RGNX REGENXBIO Inc. Buy 6.01% 12.12%
ANGO AngioDynamics, Inc. Buy 7.75% 27.9%
CUTR Cutera, Inc. Buy 4.92% -5.41%
RCM R1 RCM Inc. Buy 5.99% -1.15%
FATE Fate Therapeutics, Inc. Buy 7.67% -4.31%
CYH Community Health Systems, Inc. Buy 7.35% 3.34%
HQY HealthEquity, Inc. Buy 6.89% -3.09%
SAVA Cassava Sciences, Inc. Buy 10.59% 48.93%
HCSG Healthcare Services Group, Inc. Buy 2.51% -1.12%
RMD ResMed Inc. Buy 13.9% 2.5%
PODD Insulet Corporation Sell -3.64% 0.31%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.85% -5.24%
NKTR Nektar Therapeutics Sell -3.63% 0.74%
INGN Inogen, Inc. Sell -3.61% -0.76%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.62% -0.9%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.65% -1.69%
CPRX Catalyst Pharmaceuticals, Inc. Sell -4% 0%
The percentage of cash held in the portfolio is: 28.38%
New Assets Added
  • CPRX
Assets Removed
Asset Action Perf %
SMTI Buy All -6.87%
VRDN Sell All 27.55%
RYTM Sell All 12.98%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 7% 26.42%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.94% 11.69%
OPK OPKO Health, Inc. Buy 5.82% 8.33%
PDSB PDS Biotechnology Corporation Buy 4.64% -1.7%
AVNS Avanos Medical, Inc. Buy 6.64% 8.4%
SGRY Surgery Partners, Inc. Buy 7.49% 22.27%
RGNX REGENXBIO Inc. Buy 6.2% 12.43%
ANGO AngioDynamics, Inc. Buy 7.97% 27.73%
CUTR Cutera, Inc. Buy 5.2% -2.7%
RCM R1 RCM Inc. Buy 6.18% -1%
FATE Fate Therapeutics, Inc. Buy 7.6% -7.9%
CYH Community Health Systems, Inc. Buy 7.42% 1.38%
HQY HealthEquity, Inc. Buy 7.08% -3.16%
SAVA Cassava Sciences, Inc. Buy 8.61% 17.76%
HCSG Healthcare Services Group, Inc. Buy 2.6% -0.43%
RMD ResMed Inc. Buy 13.95% 0%
PODD Insulet Corporation Sell -3.74% 0.6%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.93% -4.51%
NKTR Nektar Therapeutics Sell -3.87% -2.96%
SMTI Sanara MedTech Inc. Sell -3.69% 0%
INGN Inogen, Inc. Sell -3.69% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.69% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.69% 0%
The percentage of cash held in the portfolio is: 15.95%
New Assets Added
  • SMTI
  • INGN
  • LXRX
  • EGRX
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 7.1% 30.89%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.95% 14.23%
OPK OPKO Health, Inc. Buy 5.7% 8.33%
PDSB PDS Biotechnology Corporation Buy 5.02% 8.52%
AVNS Avanos Medical, Inc. Buy 6.48% 8.03%
SGRY Surgery Partners, Inc. Buy 7.3% 21.76%
RGNX REGENXBIO Inc. Buy 6.1% 12.9%
ANGO AngioDynamics, Inc. Buy 7.63% 24.96%
CUTR Cutera, Inc. Buy 4.95% -5.41%
RCM R1 RCM Inc. Buy 5.95% -2.61%
FATE Fate Therapeutics, Inc. Buy 7.85% -2.87%
CLDX Celldex Therapeutics, Inc. Buy 6.87% -4.26%
SMTI Sanara MedTech Inc. Buy 6.77% -5.45%
CYH Community Health Systems, Inc. Buy 7.29% 1.77%
HQY HealthEquity, Inc. Buy 7.04% -1.69%
SAVA Cassava Sciences, Inc. Buy 8.65% 20.78%
HCSG Healthcare Services Group, Inc. Buy 2.56% 0%
PODD Insulet Corporation Sell -3.63% 1.61%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.9% -5.75%
NKTR Nektar Therapeutics Sell -3.71% -0.74%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
RMD Buy All -5.84%
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 6.8% 26.12%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.95% 14.95%
OPK OPKO Health, Inc. Buy 5.86% 12.12%
PDSB PDS Biotechnology Corporation Buy 5.06% 10.23%
AVNS Avanos Medical, Inc. Buy 6.51% 9.25%
SGRY Surgery Partners, Inc. Buy 7.46% 25.32%
RGNX REGENXBIO Inc. Buy 6.05% 12.75%
ANGO AngioDynamics, Inc. Buy 7.57% 24.8%
CUTR Cutera, Inc. Buy 5.34% 2.7%
RCM R1 RCM Inc. Buy 6.06% -0.19%
FATE Fate Therapeutics, Inc. Buy 7.84% -2.33%
PTGX Protagonist Therapeutics, Inc. Buy 6.75% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 7.24% 1.6%
SMTI Sanara MedTech Inc. Buy 7.12% 0%
CYH Community Health Systems, Inc. Buy 7.12% 0%
HQY HealthEquity, Inc. Buy 7.12% 0%
SAVA Cassava Sciences, Inc. Buy 7.12% 0%
PODD Insulet Corporation Sell -3.63% 0.85%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.84% -4.86%
NKTR Nektar Therapeutics Sell -3.74% -2.22%
RMD ResMed Inc. Sell -3.76% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RMD
  • SMTI
  • CYH
  • HQY
  • SAVA
Assets Removed
Asset Action Perf %
WAT Buy All -5.03%
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 6.73% 23.69%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.08% 16.26%
OPK OPKO Health, Inc. Buy 5.68% 7.58%
PDSB PDS Biotechnology Corporation Buy 5.19% 11.93%
AVNS Avanos Medical, Inc. Buy 6.51% 8.22%
SGRY Surgery Partners, Inc. Buy 7.24% 20.35%
RGNX REGENXBIO Inc. Buy 6.13% 13.22%
ANGO AngioDynamics, Inc. Buy 7.51% 22.51%
CUTR Cutera, Inc. Buy 4.97% -5.41%
RCM R1 RCM Inc. Buy 6.08% -0.84%
FATE Fate Therapeutics, Inc. Buy 7.86% -3.05%
PTGX Protagonist Therapeutics, Inc. Buy 7.04% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 7.2% 0%
PODD Insulet Corporation Sell -3.62% 2.09%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.89% -5.33%
NKTR Nektar Therapeutics Sell -3.75% -1.48%
WAT Waters Corporation Sell -3.74% -2.5%
The percentage of cash held in the portfolio is: 30.8%
New Assets Added
  • CLDX
Assets Removed
Asset Action Perf %
CYH Sell All 48.75%
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.14% 35.31%
VRDN Viridian Therapeutics, Inc. Buy 6.66% 19.76%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.18% 15.58%
OPK OPKO Health, Inc. Buy 5.8% 7.58%
PDSB PDS Biotechnology Corporation Buy 5.07% 6.96%
AVNS Avanos Medical, Inc. Buy 6.56% 6.7%
SGRY Surgery Partners, Inc. Buy 7.14% 16.16%
RGNX REGENXBIO Inc. Buy 5.94% 7.32%
ANGO AngioDynamics, Inc. Buy 7.49% 19.58%
CUTR Cutera, Inc. Buy 5.22% -2.7%
RCM R1 RCM Inc. Buy 6.32% 0.92%
FATE Fate Therapeutics, Inc. Buy 7.71% -7%
PTGX Protagonist Therapeutics, Inc. Buy 7.25% 0%
PODD Insulet Corporation Sell -3.77% 0.3%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.98% -5.45%
NKTR Nektar Therapeutics Sell -3.94% -4.44%
WAT Waters Corporation Sell -3.76% -0.86%
The percentage of cash held in the portfolio is: 30.99%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
EGRX Sell All 20.09%
ACAD Sell All 16.37%
Assets Rebalanced
None
2024-07-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 5.92% 28.79%
ACAD ACADIA Pharmaceuticals Inc. Buy 5.59% 14.55%
CYH Community Health Systems, Inc. Buy 6.59% 26.56%
VRDN Viridian Therapeutics, Inc. Buy 6.48% 18.17%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.15% 16.71%
OPK OPKO Health, Inc. Buy 5.81% 9.09%
PDSB PDS Biotechnology Corporation Buy 5.62% 20.17%
AVNS Avanos Medical, Inc. Buy 6.5% 7.18%
SGRY Surgery Partners, Inc. Buy 6.73% 10.92%
RGNX REGENXBIO Inc. Buy 5.8% 6.22%
ANGO AngioDynamics, Inc. Buy 7.54% 22.02%
CUTR Cutera, Inc. Buy 5.65% 6.76%
RCM R1 RCM Inc. Buy 6.37% 3.07%
FATE Fate Therapeutics, Inc. Buy 8.17% 0%
PODD Insulet Corporation Sell -3.76% -0.92%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.94% -5.61%
NKTR Nektar Therapeutics Sell -4.08% -9.63%
WAT Waters Corporation Sell -3.66% 0.62%
The percentage of cash held in the portfolio is: 26.52%
New Assets Added
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-07-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 6.02% 29.24%
ACAD ACADIA Pharmaceuticals Inc. Buy 5.65% 14.17%
CYH Community Health Systems, Inc. Buy 6.51% 23.44%
VRDN Viridian Therapeutics, Inc. Buy 6.3% 13.4%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.23% 16.66%
OPK OPKO Health, Inc. Buy 5.97% 10.61%
PDSB PDS Biotechnology Corporation Buy 5.25% 10.8%
AVNS Avanos Medical, Inc. Buy 6.53% 6.28%
SGRY Surgery Partners, Inc. Buy 6.78% 10.29%
RGNX REGENXBIO Inc. Buy 5.56% 0.47%
ANGO AngioDynamics, Inc. Buy 7.28% 16.31%
CUTR Cutera, Inc. Buy 5.91% 10.14%
RCM R1 RCM Inc. Buy 6.4% 2.15%
PODD Insulet Corporation Sell -3.76% 0.37%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.92% -3.93%
NKTR Nektar Therapeutics Sell -4.08% -8.15%
WAT Waters Corporation Sell -3.79% -1.49%
The percentage of cash held in the portfolio is: 35.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
FGEN Buy All -22.33%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings